These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7200273)

  • 1. Chemosensitivity of murine renal carcinoma.
    de Vere White R; Ki Hong W; Tannenbaum M; Olsson CA
    Urol Res; 1982 Feb; 10(1):27-30. PubMed ID: 7200273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new animal model for testing the effectiveness of chemotherapeutic agents on renal adenocarcinoma.
    White RD; Previte S; Olsson CA
    Surg Forum; 1978; 29():629-31. PubMed ID: 401284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of cytoreductive surgery on the response to chemotherapy of a rat renal cancer.
    deVere White R; Deitch AD; Hong WK; Olsson CA
    Urol Res; 1985; 13(1):35-8. PubMed ID: 3992765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate.
    Katakkar SB; Franks CR
    Cancer Treat Rep; 1978 Sep; 62(9):1379-80. PubMed ID: 688282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitomycin-associated lung disease.
    Gunstream SR; Seidenfeld JJ; Sobonya RE; McMahon LJ
    Cancer Treat Rep; 1983 Mar; 67(3):301-4. PubMed ID: 6187452
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of cyclophosphamide administered alone or in combination with vindesin or cisplatin in 5 patients with bronchial adenocarcinoma.
    Lartigue-Mattei C; Chabard JL; Touzet C; Chollet P; Plagne R; Petit J; Berger JA
    Biomed Pharmacother; 1988; 42(8):555-9. PubMed ID: 3224160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
    Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
    Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.
    Hahn DM; Schimpff SC; Ruckdeschel JC; Wiernik PH
    Cancer Treat Rep; 1977 Nov; 61(8):1585-7. PubMed ID: 72603
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
    Kris MG; Gralla RJ; Kalman LA; Kelsen DP; Casper ES; Burke MT; Groshen S; Cibas IR; Bagin R; Heelan RT
    Cancer Treat Rep; 1985 Apr; 69(4):387-95. PubMed ID: 3888388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical aspects and chemotherapy of adenocarcinoma of the kidney].
    Possinger K; Hartenstein R; Ehrhart H
    Fortschr Med; 1981 Mar; 99(12):419-23. PubMed ID: 7227939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: a randomized study.
    Elliott JA; Ahmedzai S; Hole D; Dorward AJ; Stevenson RD; Kaye SB; Banham SW; Stack BH; Calman KC
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1025-32. PubMed ID: 6540685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing of chemotherapeutic agents in murine renal cell adenocarcinoma.
    Murphy GP; Williams PD
    Res Commun Chem Pathol Pharmacol; 1974 Oct; 9(2):265-77. PubMed ID: 4438832
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of an Nb-Pr-A.I.-3 (autonomous) tumor with combination chemotherapy.
    Drago JR; Worgul T
    Cancer Chemother Pharmacol; 1981; 5(3):163-6. PubMed ID: 7197592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of chemotherapeutic agents in a new murine renal carcinoma model.
    Hrushesky WJ; Murphy GP
    J Natl Cancer Inst; 1974 Apr; 52(4):1117-22. PubMed ID: 4826582
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer.
    Itri LM; Gralla RJ; Kelsen DP; Chapman RA; Casper ES; Braun DW; Howard JE; Golbey R; Heelan RT
    Cancer; 1983 Mar; 51(6):1050-5. PubMed ID: 6185210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The response of the stilbestrol-induced renal tumor to chemotherapeutic agents.
    DeKernion JB; Resnick ML; Persky L
    J Surg Oncol; 1973; 5(1):53-8. PubMed ID: 4267819
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prospects of new chemotherapies].
    Sculier JP; Klastersky J
    Rev Med Brux; 1982 Oct; 3(8):519-27. PubMed ID: 6897459
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of non-small-cell cancer.
    Soukop M
    Recent Results Cancer Res; 1984; 92():79-88. PubMed ID: 6204364
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II evaluation of vindesine for patients with advanced colorectal carcinoma.
    Saiers JH; Slavik M; McKinney DR
    Cancer Treat Rep; 1982 Mar; 66(3):583-4. PubMed ID: 7060047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.